NCT06965465View on ClinicalTrials.gov

A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults

PHASE1RecruitingINTERVENTIONAL

Enrollment

53

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 4, 2026

Study Completion Date

June 4, 2026

Conditions

Healthy

Interventions

BIOLOGICAL

PF-07999415

Participants will receive single doses of PF-07999415.

DRUG

Placebo

Participants will receive matching placebo.

Trial Locations (1)

B-1070

RECRUITING

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT06965465 - A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults | Biotech Hunter | Biotech Hunter